Facebook Twitter YouTube

The Metastatic Breast Cancer Alliance:

Transforming and improving the lives of women and men living with metastatic breast cancer.

Metastatic Breast Cancer Landscape Analysis Oct 2014

Read the Summary Read the Full Report Read the Press Release

The Metastatic Breast Cancer Alliance unifies the efforts of its members to improve the lives of and outcomes for those living with metastatic breast cancer and their families through increasing awareness and education about the disease and advancing policy and strategic coordination of research funding specifically focused on metastasis that has the potential to extend life, enhance quality of life and ultimately to cure.


All Metastatic Breast Cancer patients and their caregivers can access the care and services they need from a responsive and well-informed healthcare system.


Metastatic Breast Cancer stakeholders — including those diagnosed and their families, health care providers, researchers, health policy influencers and policy makers — understand the disease and how it differs from early stage breast cancer.


Metastatic Breast Cancer research focuses on extending life, enhancing quality of life and ultimately ending death from the disease.

Support for the launch of the Alliance, and some of the activities of the Alliance, is being provided by
AstraZeneca, Celgene, Eisai, Genentech, Lilly Oncology, Novartis Oncology and Pfizer.

Celgene Celgene Eisai Genentech Lilly Novartis Pfizer
The Avon Foundation for Women is proud to lead and coordinate the activities of the Alliance.